The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Neutralisation of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring
Abstract
Exogenous addition of neutralising antibody to transforming growth factor-β1,2 to cutaneous wounds in adult rodents reduces scarring. Three isoforms of transforming growth factor-β (1, 2 and 3) have been identified in mammals. We investigated the isoform/isoforms of TGF-β responsible for cutaneous scarring by: (i) reducing specific endogenous TGF-β isoforms by exogenous injection of isoform specific neutralising antibodies; and (ii) increasing the level of specific TGF-β isoforms by exogenous infiltration into the wound margins. Exogenous addition of neutralising antibody to TGF-β1 plus neutralising antibody to TGF-β2 reduced the monocyte and macrophage profile, neovascu-larisation, fibronectin, collagen III and collagen I deposi-tion in the early stages of wound healing compared to control wounds. Treatment with neutralising antibodies to TGF-βs 1 and 2 markedly improved the architecture of the neodermis to resemble that of normal dermis and reduced scarring while the control wounds healed with scar formation. Exogenous addition of neutralising antibody to TGF-β1 alone also reduced the monocyte and macrophage profile, fibronectin, collagen III and collagen I deposition compared to control wounds. However, treatment with neutralising antibody to TGF-β1 alone only marginally reduced scarring. By contrast, wounds treated with neu-tralising antibody to TGF-β2 alone did not differ from control wounds. Interestingly, exogenous addition of the TGF-β3 peptide also reduced the monocyte and macrophage profile, fibronectin, collagen I and collagen III deposition in the early stages of wound healing and markedly improved the architecture of the neodermis and reduced scarring. By contrast, wounds treated with either TGF-β1 or with TGF-β2 had more extracellular matrix deposition in the early stages of wound healing but did not differ from control wounds in the final quality of scarring. This study clearly demonstrates isoform specific differ-ences in the role of TGF-βs in wound healing and cutaneous scarring. TGF-β1 and TGF-β2 are implicated in cutaneous scarring. This study also suggests a novel therapeutic use of exogenous recombinant, TGF-β3 as an anti-scarring agent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1
Border, W. A., Okuda, S., Languino, L. R., Sporn, M. B., & Ruoslahti, E. (1990) · Nature · doi:10.1038/346371a0 · Cited by 988
Accelerated Healing of Incisional Wounds in Rats Induced by Transforming Growth Factor-β
Mustoe, T. A., Pierce, G. F., Thomason, A., Gramates, P., Sporn, M. B., & Deuel, T. F. (1987) · Science · doi:10.1126/science.2442813 · Cited by 941
Broekelmann, T. J., Limper, A. H., Colby, T. V., & McDonald, J. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6642 · Cited by 794
The Transforming Growth Factor-βs
Roberts, A. B., & Sporn, M. B. (1990) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-49295-2_8 · Cited by 746
Girden, E. (1992) · Sage eBooks · doi:10.4135/9781412983419 · Cited by 732
Pelton, R. W., Saxena, B., Jones, M., Moses, H. L., & Gold, L. I. (1991) · The Journal of cell biology · doi:10.1083/jcb.115.4.1091 · Cited by 670
Transforming Growth Factors β1 and α in Chronic Liver Disease: Effects of Interferon Alfa Therapy
Castilla, A., Prieto, J., & Fausto, N. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104043241401 · Cited by 655
Control of scarring in adult wounds by neutralising antibody to transforming growth factor β
Shah, M., Foreman, D. M., & Ferguson, M. W. J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90009-r · Cited by 613
Self-citationNeutralising antibody to TGF-β1,2 reduces cutaneous scarring in adult rodents
Shah, M., Foreman, D. M., & Ferguson, M. W. J. (1994) · Journal of Cell Science · doi:10.1242/jcs.107.5.1137 · Cited by 498
Self-citationMillan, F. A., Denhez, F., Kondaiah, P., & Akhurst, R. J. (1991) · Development · doi:10.1242/dev.111.1.131 · Cited by 498
Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye.
Connor, T. B., Roberts, A. B., Sporn, M. B., Danielpour, D., Dart, L. L., Michels, R. G., de Bustros, S., Enger, C., Kato, H., & Lansing, M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114065 · Cited by 481
Sporn, M. B., Roberts, A. B., Shull, J. H., Smith, J. M., Ward, J. M., & Sodek, J. (1983) · Science · doi:10.1126/science.6572416 · Cited by 443
The extracellular matrix of lip wounds in fetal, neonatal and adult mice
Whitby, D. J., & Ferguson, M. W. J. (1991) · Development · doi:10.1242/dev.112.2.651 · Cited by 388
Self-citationInactivation of the Type II Receptor Reveals Two Receptor Pathways for the Diverse TGF-β Activities
Chen, R.-H., Ebner, R., & Derynck, R. (1993) · Science · doi:10.1126/science.8388126 · Cited by 384
Pelton, R. W., Dickinson, M. E., Moses, H. L., & Hogan, B. L. M. (1990) · Development · doi:10.1242/dev.110.2.609 · Cited by 324
Differential expression of TGF β 1, β 2 and β 3 genes during mouse embryogenesis
Schmid, P., Cox, D., Bilbe, G., Maier, R., & Mcmaster, G. K. (1991) · Development · doi:10.1242/dev.111.1.117 · Cited by 290
Graycar, J. L., Miller, D. A., Arrick, B. A., Lyons, R. M., Moses, H. L., & Derynck, R. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-12-1977 · Cited by 272
Siegbahn, A., Hammacher, A., Westermark, B., & Heldin, C. H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114519 · Cited by 255
Bascom, C. C., Wolfshohl, J. R., Coffey, R. J., Madisen, L., Webb, N. R., Purchio, A. R., Derynck, R., & Moses, H. L. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.12.5508 · Cited by 215
Jennings, J. C., Mohan, S., Linkhart, T. A., Widstrom, R., & Baylink, D. J. (1988) · Journal of Cellular Physiology · doi:10.1002/jcp.1041370120 · Cited by 191
TGF-β Regulates Production of Growth Factors and TGF-β by Human Peripheral Blood Monocytes
McCartney-Francis, N., Mizel, D., Wong, H., Wahl, L., & Wahl, S. (1990) · Growth Factors · doi:10.3109/08977199009011007 · Cited by 173
Vascular cells respond differentially to transforming growth factors beta 1 and beta 2 in vitro.
Merwin, J. R., Newman, W., Beall, L. D., Tucker, A., & Madri, J. A. (1991) · PubMed · Cited by 147
Expression of TGF-β isoforms during first trimester human embryogenesis
Gatherer, D., ten Dijke, P., Baird, D. T., & Akhurst, R. J. (1990) · Development · doi:10.1242/dev.110.2.445 · Cited by 137
Danielpour, D., Kim, K.-Y., Dart, L. L., Watanabe, S., Roberts, A. B., & Sporn, M. B. (1989) · Growth Factors · doi:10.3109/08977198909069082 · Cited by 124
Regional Differences in the Growth of Normal and Neoplastic Cells
Auerbach, R., & Auerbach, W. (1982) · Science · doi:10.1126/science.7053564 · Cited by 97
Regulation of epithelial cell proliferation by transforming growth factors
Bascom, C. C., Sipes, N. J., Coffey, R. J., & Moses, H. L. (1989) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240390104 · Cited by 71
Mesoderm Induction in Xenopus laevis Distinguishes Between the Various TGF-β Isoforms
Roberts, A. B., Kondaiah, P., Rosa, F., Watanabe, S., Good, P. J., Danielpour, D., Roche, N. S., Rebbert, M. L., Dawid, I. B., & Sporn, M. B. (1990) · Growth Factors · doi:10.3109/08977199009003670 · Cited by 65
Ksander, G. A., Ogawa, Y., CHU, G. H., McMullin, H., Rosenblatt, J., & McPherson, J. M. (1990) · PubMed Central · Cited by 65
Lepistö, J., Laato, M. K., Niinikoski, J., Lundberg, C., Gerdin, B., & Heldin, C. (1992) · Journal of Surgical Research · doi:10.1016/0022-4804(92)90260-7 · Cited by 63
Platelet-derived growth factors: A family of isoforms that bind to two disticnt receptors
Heldin, C., & Westermark, B. (1989) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072334 · Cited by 63
O’Reilly, M. A., Danielpour, D., Roberts, A. B., & Sporn, M. B. (1992) · Growth Factors · doi:10.3109/08977199209026926 · Cited by 26
Cited by
Singer, A. J., & Clark, R. A. F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411006 · Cited by 6,106
Wound Healing--Aiming for Perfect Skin Regeneration
Martin, P. (1997) · Science · doi:10.1126/science.276.5309.75 · Cited by 4,804
Regulation of Wound Healing by Growth Factors and Cytokines
WERNER, S., & GROSE, R. (2003) · Physiological Reviews · doi:10.1152/physrev.2003.83.3.835 · Cited by 3,629
PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing
Barrientos, S., Stojadinovic, O., Golinko, M. S., Brem, H., & Tomic‐Canic, M. (2008) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2008.00410.x · Cited by 3,583
Pathophysiology of acute wound healing
Li, J., Chen, J., & Kirsner, R. (2007) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2006.09.007 · Cited by 1,486
Metadata
- Authors
- Shah, M., Foreman, D. M., & Ferguson, M. W. J.
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 1995-03-01
- Volume
- 108
- Issue
- 3
- Pages
- 985-1002
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W2123550509
- Cited by
- 1,169
- References
- 31
- FWCI
- 44.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.